ClinConnect ClinConnect Logo
Search / Trial NCT05269225

Organic Diet in Pregnancy and Risk Markers of Health Effects (The OrgDiet Project)

Launched by PER OLE IVERSEN, MD · Feb 24, 2022

Trial Information

Current as of June 27, 2025

Recruiting

Keywords

ClinConnect Summary

The OrgDiet Project is a research study that wants to find out how eating organic foods during pregnancy affects the health of both mothers and their babies. In this study, pregnant women will be divided into two groups: one group will eat organic foods, while the other group will eat conventional foods. Both groups will also follow healthy eating guidelines from Norway. The study will include about 100 participants, and researchers will keep track of the mothers and their children until the children are two years old.

To join this study, women must be pregnant in their first trimester and can either be having their first baby or already have children. However, women who regularly eat organic foods, take certain medications, have chronic health issues, or suffer from food allergies won’t be able to participate. If you join, you can expect support in following the dietary guidelines and contributing to important research that could help future mothers and babies.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • Nulli- or multipara pregnant in first trimester
  • Exclusion Criteria:
  • Consuming an organic diet regularly
  • Using medication regularly that might interfere with study adherence or - outcomes
  • Diagnosed with a chronic disorder or cancer
  • Having a food allergy or intolerance

About Per Ole Iversen, Md

Per Ole Iversen, MD, is a distinguished clinical trial sponsor known for his commitment to advancing medical research and improving patient outcomes. With extensive expertise in clinical medicine and trial design, Dr. Iversen leads innovative studies that focus on evaluating new therapies and treatment modalities across various therapeutic areas. His dedication to rigorous scientific methodologies and ethical standards ensures the integrity and reliability of clinical findings. Through collaboration with research institutions and healthcare professionals, Dr. Iversen aims to contribute to the body of knowledge that drives evidence-based practice in medicine.

Locations

Oslo, , Norway

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials